BCG vaccination provides protection against unrelated viral infections. The vaccine induces protective integrated organ immunity through biphasic activation of innate and adaptive immune cells.
References
Ziogas, A., Bruno, M., van der Meel, R., Mulder, W. J. M. & Netea, M. G. Cell Host Microbe 31, 1776–1791 (2023).
Mantovani, A. & Netea, M. G. N. Engl. J. Med. 383, 1078–1080 (2020).
Lee, A. Nat. Immunol. https://doi.org/10.1038/s41590-023-01700-0 (2023).
Pittet, L. F. et al. N. Engl. J. Med. 388, 1582–1596 (2023).
Pereira, S. M. et al. BMC Med. 21, 145 (2023).
Faustman, D. L. et al. Cell Rep. Med. 3, 100728 (2022).
Moorlag, S., Arts, R. J. W., van Crevel, R. & Netea, M. G. Clin. Microbiol. Infect. 25, 1473–1478 (2019).
Kleinnijenhuis, J. et al. Proc. Natl Acad. Sci. USA 109, 17537–17542 (2012).
Kaufmann, E. et al. Cell Rep. 38, 110502 (2022).
Wilczek, N. A. et al. J. Clin. Med. 12 (2023).
Malmstrom, P. U. et al. Eur. Urol. 56, 247–256 (2009).
Hilligan, K. L. et al. Nat. Commun. https://doi.org/10.1038/s41467-023-43447-0 (2023).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The author declares no competing interests.
Rights and permissions
About this article
Cite this article
Rescigno, M. BCG-mediated viral protection goes biphasic. Nat Immunol 25, 13–14 (2024). https://doi.org/10.1038/s41590-023-01713-9
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41590-023-01713-9
- Springer Nature America, Inc.